Showing results (91-100 of 404) with videos related to
Sort By:
Pageof 41
Cancer Immunology, Immunotherapy : CII|October 26, 2018
Inhibitory functions of PD-L1 and PD-L2 in the regulation of anti-tumor immunity in murine tumor microenvironmentDaisuke Umezu, Nana Okada, Yukimi Sakoda, et al.Journal of Robotic Surgery|August 7, 2024
Functional outcomes in robot-assisted partial nephrectomy with three-dimensional images reconstructed from computed tomography: a propensity score-matched comparative analysisSatoshi Kobayashi, Keiji Tsukino, Jun Mutaguchi, et al.Surgical Case Reports|December 2, 2020
A rare case of PSA-negative metastasized prostate cancer to the stomach with serum CEA and CA19-9 elevation: a case reportKoji Shindo, Kenoki Ohuchida, Taiki Moriyama, et al.Asian Journal of Endoscopic Surgery|November 26, 2024
Laparoscopic Retroperitoneal Lymph Node Dissection After Chemotherapy for Nonseminomatous Testicular Germ-Cell Tumor at a Single CenterMasaki Shiota, Tokiyoshi Tanegashima, Shigehiro Tsukahara, et al.The Journal of Dermatology|October 16, 2025
Enfortumab Vedotin-Related Skin Toxicities: Insights From Clinical and Histopathological AnalysisYuki Kuma, Makiko Kido-Nakahara, Yoko Kuba-Fuyuno, et al.The Journal of Urology|October 30, 2010
Mechanism of synergistic antitumor effect of sorafenib and interferon-α on treatment of renal cell carcinomaArio Takeuchi, Masatoshi Eto, Katsunori Tatsugami, et al.Molecular Medicine Reports|September 22, 2011
p300 mediates cellular resistance to doxorubicin in bladder cancerArio Takeuchi, Masaki Shiota, Katsunori Tatsugami, et al.Andrologia|August 8, 2018
Serum testosterone before and during androgen-deprivation therapy, and prognosis between cigarette smokers and nonsmokers with metastatic prostate cancerMasaki Shiota, Eiji Kashiwagi, Tomohiko Murakami, et al.Urologic Oncology|November 18, 2018
Serum testosterone level as possible predictive marker in androgen receptor axis-targeting agents and taxane chemotherapies for castration-resistant prostate cancerMasaki Shiota, Eiji Kashiwagi, Tomohiko Murakami, et al.Pathology, Research and Practice|March 29, 2023
Prognostic impact of CD73/adenosine 2A receptor (A2AR) in renal cell carcinoma and immune microenvironmental status with sarcomatoid changes and rhabdoid featuresDai Takamatsu, Daisuke Kiyozawa, Kenichi Kohashi, et al.Pageof 41